Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway) (Homo sapiens)
From WikiPathways
Description
Hypothetical pathway for complement-mediated inflammation of the pulmonary alveolus in COVID-19.
AEC‐II=Type II alveolar epithelial cell, EC=endothelial cells and MC=monocytes.
Quality Tags
Ontology Terms
Bibliography
- Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S; ''Rationale for targeting complement in COVID-19.''; EMBO Mol Med, 2020 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
ACE2 | GeneProduct | ENSG00000130234 (Ensembl) | |
C3AR1 | GeneProduct | ENSG00000171860 (Ensembl) | |
C3 | GeneProduct | ENSG00000125730 (Ensembl) | |
C5AR1 | GeneProduct | ENSG00000197405 (Ensembl) | |
C5 | GeneProduct | ENSG00000106804 (Ensembl) | |
C5b | GeneProduct | ENSG00000106804 (Ensembl) | |
C6 | GeneProduct | ENSG00000039537 (Ensembl) | |
C7 | GeneProduct | ENSG00000112936 (Ensembl) | |
C8 | GeneProduct | 731 (Entrez Gene) | |
C9 | GeneProduct | ENSG00000113600 (Ensembl) | |
Coagulaton activation | Pathway | WP558 (WikiPathways) | |
Collectin-11 | Protein | F8WB29 (Uniprot-TrEMBL) | |
Complement activation | Pathway | WP545 (WikiPathways) | |
Ficolin-1 | Protein | O00602 (Uniprot-TrEMBL) | |
MASP2 | GeneProduct | ENSG00000009724 (Ensembl) |
Annotated Interactions
No annotated interactions